{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:45:20Z","timestamp":1790790320776,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.ijrobp.2016.01.046","type":"journal-article","created":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T12:17:48Z","timestamp":1454329068000},"page":"78-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Disruption of SLX4-MUS81 Function Increases\u00a0the Relative Biological Effectiveness of Proton Radiation"],"prefix":"10.1016","volume":"95","author":[{"given":"Qi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy S.A.","family":"Underwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong","family":"Kung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiao-Ming","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Paganetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn D.","family":"Held","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore S.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Efstathiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Willers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2016.01.046_bib1","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0360-3016(02)02754-2","article-title":"Relative biological effectiveness (RBE) values for proton beam therapy","volume":"53","author":"Paganetti","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.01.046_bib2","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.ijrobp.2013.05.002","article-title":"High-dose hypofractionated proton beam radiation therapy is safe and effective for central and peripheral early-stage non-small cell lung cancer: Results of a 12-year experience at Loma Linda University Medical Center","volume":"86","author":"Bush","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.01.046_bib3","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1002\/cncr.25848","article-title":"Early findings on toxicity of proton beam therapy with concurrent chemotherapy for nonsmall cell lung cancer","volume":"117","author":"Sejpal","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2016.01.046_bib4","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1097\/JTO.0b013e31824de0bf","article-title":"Proton SBRT for medically inoperable stage I NSCLC","volume":"7","author":"Westover","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2016.01.046_bib5","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.ijrobp.2014.12.046","article-title":"Lung Cancer Cell Line Screen Links Fanconi Anemia\/BRCA Pathway Defects to Increased Relative Biological Effectiveness of Proton Radiation","volume":"91","author":"Liu","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.01.046_bib6","series-title":"DNA Repair in Cancer Therapy: Molecular Targets and Clinical Applications","article-title":"Targeting homologous recombination repair in cancer","author":"Willers","year":"2012"},{"key":"10.1016\/j.ijrobp.2016.01.046_bib7","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/nature08467","article-title":"The DNA-damage response in human biology and disease","volume":"461","author":"Jackson","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.ijrobp.2016.01.046_bib8","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.cell.2014.12.031","article-title":"SnapShot: Fanconi anemia and associated proteins","volume":"160","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ijrobp.2016.01.046_bib9","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.molcel.2015.07.009","article-title":"A dominant mutation in human RAD51 reveals its function in DNA interstrand crosslink repair independent of homologous recombination","volume":"59","author":"Wang","year":"2015","journal-title":"Mol Cell"},{"key":"10.1016\/j.ijrobp.2016.01.046_bib10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1158\/2159-8290.CD-14-1156","article-title":"Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype","volume":"5","author":"Sawyer","year":"2015","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ijrobp.2016.01.046_bib11","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1182\/blood-2012-07-441212","article-title":"Regulation of multiple DNA repair pathways by the Fanconi anemia protein SLX4","volume":"121","author":"Kim","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2016.01.046_bib12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.celrep.2013.08.041","article-title":"Human GEN1 and the SLX4-associated nucleases MUS81 and SLX1 are essential for the resolution of replication-induced Holliday junctions","volume":"5","author":"Garner","year":"2013","journal-title":"Cell Rep"},{"key":"10.1016\/j.ijrobp.2016.01.046_bib13","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1101\/gad.238303.114","article-title":"Roles of SLX1-SLX4, MUS81-EME1, and GEN1 in avoiding genome instability and mitotic catastrophe","volume":"28","author":"Sarbajna","year":"2014","journal-title":"Genes Dev"},{"key":"10.1016\/j.ijrobp.2016.01.046_bib14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cell.2009.06.030","article-title":"Mammalian BTBD12\/SLX4 assembles a Holliday junction resolvase and is required for DNA repair","volume":"138","author":"Svendsen","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ijrobp.2016.01.046_bib15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.dnarep.2015.01.011","article-title":"Alterations of DNA repair genes in the NCI-60 cell lines and their predictive value for anticancer drug activity","volume":"28","author":"Sousa","year":"2015","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.ijrobp.2016.01.046_bib16","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/JTO.0b013e31827ecf83","article-title":"Detection of impaired homologous recombination repair in NSCLC cells and tissues","volume":"8","author":"Birkelbach","year":"2013","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2016.01.046_bib17","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.radonc.2015.08.014","article-title":"Differential DNA repair pathway choice in cancer cells after proton- and photon-irradiation","volume":"116","author":"Fontana","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2016.01.046_bib18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijrobp.2013.09.041","article-title":"Deficiency in homologous recombination renders mammalian cells more sensitive to proton versus photon irradiation","volume":"88","author":"Grosse","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.01.046_bib19","doi-asserted-by":"crossref","first-page":"6492","DOI":"10.1073\/pnas.1018487108","article-title":"Involvement of SLX4 in interstrand cross-link repair is regulated by the Fanconi anemia pathway","volume":"108","author":"Yamamoto","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijrobp.2016.01.046_bib20","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.molcel.2014.03.015","article-title":"XPF-ERCC1 acts in unhooking DNA interstrand crosslinks in cooperation with FANCD2 and FANCP\/SLX4","volume":"54","author":"Klein Douwel","year":"2014","journal-title":"Mol Cell"},{"key":"10.1016\/j.ijrobp.2016.01.046_bib21","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1126\/science.1094557","article-title":"Involvement of mammalian Mus81 in genome integrity and tumor suppression","volume":"304","author":"McPherson","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.ijrobp.2016.01.046_bib22","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1259\/0007-1285-34-401-313","article-title":"The relative biological efficiency of x rays generated at 220 kVp and gamma radiation from a cobalt 60 therapy unit","volume":"34","author":"Hall","year":"1961","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ijrobp.2016.01.046_bib23","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/09553009214551031","article-title":"The relative biological effectiveness of 60Co gamma-rays, 55 kVp X-rays, 250 kVp X-rays, and 11 MeV electrons at low doses","volume":"61","author":"Spadinger","year":"1992","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.ijrobp.2016.01.046_bib24","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1083\/jcb.201104003","article-title":"Mus81-mediated DNA cleavage resolves replication forks stalled by topoisomerase I-DNA complexes","volume":"195","author":"Regairaz","year":"2011","journal-title":"J Cell Biol"},{"key":"10.1016\/j.ijrobp.2016.01.046_bib25","doi-asserted-by":"crossref","first-page":"7569","DOI":"10.1128\/MCB.25.17.7569-7579.2005","article-title":"Disruption of murine Mus81 increases genomic instability and DNA damage sensitivity but does not promote tumorigenesis","volume":"25","author":"Dendouga","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ijrobp.2016.01.046_bib26","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ccr.2012.05.015","article-title":"A distinct replication fork protection pathway connects Fanconi anemia tumor suppressors to RAD51-BRCA1\/2","volume":"22","author":"Schlacher","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ijrobp.2016.01.046_bib27","doi-asserted-by":"crossref","first-page":"6254","DOI":"10.1158\/0008-5472.CAN-13-0044","article-title":"EGFR-activating mutations correlate with a Fanconi anemia-like cellular phenotype that includes PARP inhibitor sensitivity","volume":"73","author":"Pf\u00e4ffle","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2016.01.046_bib28","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1667\/RR13904.1","article-title":"The major DNA repair pathway after both proton and carbon-ion radiation is NHEJ, but the HR pathway is more relevant in carbon ions","volume":"183","author":"Gerelchuluun","year":"2015","journal-title":"Radiat Res"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301616000961?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301616000961?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:43:34Z","timestamp":1759743814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301616000961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0360301616000961"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2016.01.046","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disruption of SLX4-MUS81 Function Increases\u00a0the Relative Biological Effectiveness of Proton Radiation","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2016.01.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}